Clinical Trial Update: Dysbiosis Impact on Lung Disease in HIV

View source ↗

Summary

A completed clinical trial assessed the impact of dysbiosis on lung disease in people with HIV, including those with COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Human Immunodeficiency Virus Infection

Snippet

Sponsor: University of Pittsburgh | Conditions: HIV Infections, COPD | Status: COMPLETED